Antibodies over-produced by the Thymus gland that causes MG.
Asymmetric, progressive degeneration of the motor neurons leading to severe fatigue and muscle atrophy due to overstimulation of glutamate (abrev.).
Patho: progressive immune demyelination resulting in different patterns of motor, sensory, cerebellar, bowel/bladder, emotional, and sexual dysfunction (abrev.).
Drug used to enhance the duration of carbidopa/levodopa; a COM inhibitor, for short.
Peripheral acetylcholinesterase inhibitor central to the treatment of MG.
Immunotherapy used to quickly reverse an acute exacerbation of MG or GBS (abrev.).
Corticosteroid medication used for many autoimmune exacerbations including MS and MG.
Patho: Autoimmune disease where the body produces anti-AcH antibodies resulting in profound fatigue and severe muscle weakness (abrev.).
A life-threatening idiosyncratic reaction to antipsychotic drugs characterized by fever, altered mental status, muscle rigidity, and autonomic dysfunction; associated with a variety of other medications that affect central dopaminergic neurotransmission. (Abrev.)
Progressive, neurodegenerative disease of the basal ganglia and cerebral cortex caused by an abnormality of the gene on chromosome 4 (abrev.).
Drug used to deplete monoamine oxidase which in turn diminishes dopamine transmission and reduces choreiform movements in HD; can cause neuroleptic malignant syndrome (NMS).
Drug that slows the progression of of ALS by blocking the action of glutamate.
Central acetylcholinesterase inhibitor used for cognitive impairment in MS and Alzheimer's disease.
Muscle relaxer used for spasticity in MS, HD, and other neurological disorders.
Drug that reduces muscular contraction by acting as an antagonist to the ryanodine receptor and inhibiting Ca+ release into the muscles.